Anorexia Nervosa Clinical Trial
Official title:
Cephalic Phase in Anorexia Nervosa,Bulimia Nervosa and Obese Binge Eaters
The objective of this trial is to examine the cephalic phase insulin response (CPIR) and pancreatic polypeptide (PP) release as indicators of the cephalic phase occurrence and magnitude to palatable food stimulus in anorectic and bulimic subgroups as compared to healthy controls
Food stimulation of gastric and pancreatic secretion is classically divided into cephalic,
gastric and intestinal phases.
Cephalic phase refers to a simultaneous activation of gastrointestinal motility, gastric
acid and pancreatic enzyme secretion ,as well as, release of hormones from the endocrine
pancreas which occurs through activation of vagal -efferents as a result of food-related
sensory stimuli such as taste and smell prior to nutrient absorption and which coincides
with a thermogenic response.
Of the cephalic phase secretions, cephalic phase insulin release (CPIR) has received the
most attention, but pancreatic polypeptide (PP) and glucagon responses have also been
studied. While the magnitude of cephalic phase insulin release is relatively small (25%
above baseline), pancreatic polypeptide increases 100% above baseline. The large magnitude
of the PP response makes it a sensitive indicator of vagal activation to food stimuli.
In most experiments, subjects are either exposed to visual and olfactory stimulation by
seeing and smelling the food stimulus or are required to perform a modified sham-feed, i.e.
to taste, chew and then expectorate the food stimulus.
In general, cephalic phase are thought to be preparatory response before ingestion of food.
Because of their small magnitude, the physiological significance of the cephalic phase
hormonal responses has been largely discounted. However, there is evidence that experimental
prevention of CPIR lead to hyperinsulinemia and hyperglycemia. Therefore, CPIR may
contribute to glucose homeostasis /regulation. Moreover CPIR may be an indicator of hunger
and could be important for understanding eating disorders.
In parallel with these hormonal secretion ,an increase in energy expenditure has also been
observed . This thermogenic response to food is even greater with sham feeding than with
normal feeding and is paralleled by changes in RQ showing enhanced carbohydrate oxidation.
Studies conducted in obese humans demonstrate exaggerated absolute magnitude of CPIR
.However basal hyper-insulinemia which is typically observed in obese individuals may clouds
this observation. Moreover, it has been hypothesized that CPIR is attenuated in obese when
is expressed as a percentage of baseline and therefore they may not secrete enough insulin
during pre-absorptive period to regulate postprandial glucose levels.
There is also evidence that obese people with insulin resistance have a reduced thermogenic
response to feeding .
Only limited numbers of studies have been done on the cephalic phase in anorexia and
bulimia. There are findings of a significant CPIR in anorexics as compared to controls which
tends to rule out a deficient cephalic insulin response as a contributor to the
self-starvation observed in anorexia nervosa. As to bulimics who often show endocrine
abnormalities, their CPIR was only slightly differ or from controls.
These findings suggest more complex determinants of eating disorders than physiological
state alone.
;
Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05531604 -
Appetitive Conditioning in Anorexia Nervosa
|
||
Enrolling by invitation |
NCT04174703 -
Preparing for Eating Disorders Treatment Through Compassionate Letter-Writing
|
N/A | |
Active, not recruiting |
NCT04883554 -
Impact of an Olfactory Sensory Therapeutic Group for Adolescent Patients With Restrictive Anorexia Nervosa , Pilot Study
|
N/A | |
Recruiting |
NCT04213820 -
TMS and Body Image Treatment for Anorexia Nervosa
|
N/A | |
Completed |
NCT03414112 -
The Impact of Oxytocin on the Neurobiology of Anorexia Nervosa
|
Early Phase 1 | |
Recruiting |
NCT06144905 -
Norwegian Microbiota Study in Anorexia Nervosa
|
||
Recruiting |
NCT05803707 -
Home-based Adapted Physical Activity in Anorexia Nervosa: a Feasibility Pilot Study
|
N/A | |
Recruiting |
NCT05682417 -
Impact of Body Schema Distortion on Remission and Weight Regain in Anorexia Nervosa
|
N/A | |
Not yet recruiting |
NCT06380257 -
Anorexia Nervosa and Brain in Adolescence
|
||
Not yet recruiting |
NCT04804800 -
Virtual Reality Place in the Management of Body Dysmorphia Disorders in Anorexia Nervosa
|
N/A | |
Not yet recruiting |
NCT03600610 -
Evaluation of CARdiac Abnormalities by Echocardiography and MRI in Malnourished Patients Suffering From Anorexia Nervosa
|
N/A | |
Completed |
NCT02745067 -
Effectiveness of Enhanced Cognitive Behavioral Therapy (CBT-E) in the Treatment of Anorexia Nervosa
|
N/A | |
Completed |
NCT02382055 -
Changing Habits in Anorexia Nervosa: Novel Treatment Development
|
N/A | |
Terminated |
NCT02240797 -
Kappa Opioid Receptor Imaging in Anorexia
|
N/A | |
Completed |
NCT03075371 -
Homeostatic and Non-homeostatic Processing of Food Cues in Anorexia Nervosa
|
N/A | |
Unknown status |
NCT01761942 -
Fatty Acids Omega -3 Diet Supplementation Efficiency and Safety Evaluation in Anorexia Nervosa
|
Phase 2 | |
Completed |
NCT03144986 -
Insula-coil Deep TMS for Treatment Resistant Anorexia Nervosa
|
N/A | |
Completed |
NCT02551445 -
A fMRI Pilot Study of the Effects of Meal-support in Eating Disorders.
|
N/A | |
Completed |
NCT01579682 -
Adaptive Family Treatment for Adolescent Anorexia Nervosa
|
N/A | |
Completed |
NCT00946816 -
The Effects of Dietary Intervention on Gastrointestinal Function in Patients With Anorexia Nervosa and Obesity
|
N/A |